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CASE REPORT
INTRODUCTION
Candida is part of the normal flora in many areas
of the body and without alteration in host defense, does
not cause disease. Factors particularly important to
preventing infection are normal bacterial flora, intact
skin and mucous membranes within the GI tract and
normal cell-mediated immunity.1-3
In the United State, Candida species are
ubiquitous and colonize also in healthy people. Up to
14% of patients with immunocompromising disease
develop systemic candidiasis. Candida albicans is the
most common cause of esophagitis. Most Candida
infections are superficial and are associated with death
in as many as 77%.2
Oropharyngeal candidiasis (OPC) is most
prevalent in infants, elderly, compromised hosts and
occurs in association with serious underlying condition
including diabetes, leukemia, neoplasia, steroid use,
antimicrobial therapy, radiation therapy and HIV
infection. Esophageal Candidiasis presents with a range
of clinical findings. Between 20-50% of patient may
be asymptomatic, others will note dysphagia
odynophagia epigastric pain, nausea and vomiting or
hematemesis. Constitutional findings, including fever,
only occasionally occur. Although Candida esophagitis
may arise as an extension of oropharyngeal
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Esophageal candidiasis presents with a range of clinical findings and is rarely found among
immunocompetent patient without predisposing factors. Between 20-50% of patient may be
asymptomatic. One of predisposing factor of candidiasis is immunocompromised condition due to
malignancy. Dysphagia is the most frequently presented feature of esophageal carcinoma.
We demonstrated a case of esophageal candidiasis as one of early clinical presentation in patient with
esophageal carcinoma.
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candidiasis, in more than 66% of cases, the esophagus
was the only site involved and more often in the distal
2/3 than in the proximal 1/3 of the esophagus.1,3
Oral mucosal candidiasis, also called oral thrush;
indicates T-cell immunodeficiency. In patients with
cancer, condition that predispose to oral candidiasis
include cytotoxic chemotheraphy causing mucosal
disruption, high dose corticosteroids and use of
broad-spectrum antibiotic.4,5
Candidiasis most often presents in one of two ways:
the Mucocutaneous Syndrome (MS) or the invasive
(deep tissue) syndrome. The MS include
oropharyngeal (thrush), esophageal and
gastrointestinal (stomach to colon) GI candisiasis,
intertrigo, vulvovaginitis (the most common form of MS),
balanitis and Chronic Mucocutaneous Candidiasis.
While invasive candidiasis of the oropharynx and
esophagus occurring in the absence of bowel or colon
should prompt an investigation for a GI malignancy.4
A reliable diagnosis of Esophageal Candidiasis can
only be made by histological evidence of tissue
invasion in biopsy material. Esophagography with
contrast is indicated for diagnosis of esophagitis caused
by Candida species. Peristaltic abnormalities caused
by small plaques appear as superficial filling defect
nodular or cobblestone pattern may be seen, findings
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may be similar to those seen with esophagitis caused
by cytomegalovirus and herpes simplex virus (HSV).
Strictures may be seen with severe esophageal
candidiasis. Endoscopy provides direct visualization of
small, white, mucosal plaques which esophageal
candidiasis, biopsies, may be obtained for a more
definitive diagnosis.1,2,4
Esophageal candidiasis is classified on the basic of
endoscopic appearance: type I, a few white or beige
plaques, up to 2 mm in diameter, type II, plaques are
more numerous, larger than 2 mm in diameter, type III,
confluent, linear and nodular elevated plaques with
hyperemia and frank ulceration and type IV, similar to
type III but with increased mucosal friability and
occasional narrowing of the lumen.3
Esophageal cancer is one of the least studied and
deadliest cancers worldwide. Cancers arising from
the esophagus, including the gastroesophageal junction,
are relatively uncommon in the United States, with
13,900 new cases and 13,000 deaths anticipated in
2003. Esophageal cancer is the seventh leading caused
of death from cancer among American men,
particularly black men, who have a higher incidence of
this disease (13 cases per 100,000 people) than do men
in other racial or ethnic groups. Worldwide, esophageal
cancer is the sixth leading cause of death from
cancer.5,6,7
More than 90% of esophageal cancers are either
squamous-cell carcinomas or adenocarcinomas, the
pathogenesis of esophageal cancer remains unclear,
smoking is associated with and increased risk of both
squamous-cell carcinoma and adenocarcinoma of the
esophagus.5,6,7
Dysphagia is the most frequently presented
feature of esophageal carcinoma, the patient may
recount a short of progressive dysphagia, initially
affecting only but gradually affecting the swallowing
of fluids. The interruption of the passage of food may
cause the individual to slowly alter from solid to liquid
nutrition, success with this approach may be at the
expensive medical self referral, and a short history of
dysphagia in an elderly male is almost certainly
carcinoma of esophagus or the cardia of the stomach.6
ILLUSTRATION
Mr. T, 54 years old, admitted to Cipto
Mangunkusumo hospital with the chief complaint
swallowing difficulties since 4 months before
admission.
Since 4 months before being admitted to the
hospital, the patient has had swallowing problem,
sometimes with pain. He felt a constriction somewhere
in his chest. His swallowing problem has been
worsened; he could only swallow half a glass of water
in an hour recently. If forced, he vomited. The patient
had also complained of hearth burns, no fever, and mild
cough without sputum when he has forced himself
swallowing food or water. The amount of food he has
consumed was decreasing. His body weight had been
reduced by 27 kg in 4 months. He had muscle
weakness. There was no history of fever and no
complain of micturition problem. His pattern of
defecation was unremarkable.
Before being admitted to Cipto Mangunkusumo
hospital, the patient was hospitalized in other
hospital. He was given intravenous fluid therapy and
he was diagnosed with achalasia.
The patient has never been hospitalized and never
experienced these symptoms before. There were no
history of diabetes mellitus, hypertension or malignancy
and nor did in his family. He had denial for the history
of using drugs like steroid or antibiotic in long period of
time, drug abuse, or free sex and smoke cigarette
a pack per day since he was 20 years old.
On the physical examination, the patient looked
moderately ill, fully conscious, blood pressure of
120/100 mm Hg, heart rate 80 times per minute,
temperature 37oC, respiratory rate 16 breaths per
minute. Heart and lung were within normal limits,
abdominal tenderness on the right quadrant, liver and
spleen were not palpable, and bowel sound was
normal.
From the laboratory examination: Hemoglobin
15.2 g/dL, leukocyte 6,700/uL, thrombocyte 350,000/
uL, ureum 26 g/dL, creatinin 0.9 mg/dL, electroytes:
natrium 135 meq/L, potassium 3.93 meq/L, urinalysis
was normal, ALT 28 U/L, AST 12 U/L, total protein
6.1, albumin 3.30, globulin 2.80, total bilirubin 0.60 and
blood uric acid 8.4 mg/dL.
The faces analysis showed blood. Oesophaghogram
showed cicatrical stenosis from esophagus suggested
appearance of achalasia esophagus. Chest X-ray
indicated bronchitis.
The working diagnosis of this patient was
achalasia, which was based on the complaint of
difficult to swollen since 4 months before admitted,
vomiting, lost of body weight 27 kg on 4 months and
difficulties to drink water or liquid food, with
differential diagnosis obstruction by tumor,
inflammation caused by nfection.
Our planned to confirm diagnosis was upper
gastrointestinal endoscopy. The treatment plans were
intravenous fluid therapy and enteral liquid diet by
nasogastric tube (NGT).
On the 2nd day of hospitalization, endoscopy was
done with result are appearance like Candidiasis
esophagus from the distal esophagus, no biopsy was
performed. From that result we considered that the
problem of this patient was odynophagia due to
esophageal candidiasis. He was given mycostatin.
Then the symptom was relieved but no completely
cured.
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On the 8th day of hospitalization, patient could eat
little of porridge, and he also complaint diarrhea 3 times
that day. There was no blood in the feces. He had
nausea, vomiting, cough and felt discomfort on his
abdomen. From the physical examination patient looked
moderately ill, hemodynamic was stable, heart and lung
were within normal range, the liver and the spleen were
not palpable and decreased bowel sound.
The result from esophageal Swab there was
colonization of Candida. Our assessment dysphagia
caused by oesophagitis due to mucosal candidiasis with
differential diagnosis was obstruction by tumor.
The plans for diagnosis were endoscopy for biopsy,
abdominal USG paracentesis ascites with guided USG.
We also check for CD4 count and cholinesterase level.
Treatment given was antifungal fluconazole 150 mg
once daily.
The result of upper gastrointestinal endoscopy was
described: Oesophagoscopy: from the distal of
oesophagus 35 from incicivus there were mass at 6
with granuler mucosa, fragile and the tumor mass was
covered almost all lumen, the scope could not pass
through, NGT was inserted by endoscopy. Conclusion
of endoscopy result was mass in distal of esophagus
with differential diagnosis esophagus carcinoma and
mass in Cardia. The abdominal USG showed right and
left lobes of hepar were contracted, irregular,
presence of diffuse SOL. The conclusion was liver
cirrhosis.
The biopsy result indicated esophagus mucosa with
a typical cell, difficult to confirmed malignancy from
this specimen. The result from laboratory examination:
non-reactive HIV, T- lymphocyte 454, T-helper limfosit
290; CEA: 1.5 mg/mL, HbsAg was negative, and anti
HCV was negative. The ascitic fluid analysis showed
yellow, reddish fluid, positive Rivalta test, cell count of
800/uL, PMN 24/ul, MN 776/uL, LDH 159 U/L,
serum LDH level of 181 U/L and total protein
concentration of 2.8 g/dL. Pathological anatomy
examination of ascitic fluid showed epithelial cell like
mesotel andalteration to malignancy. The 3rd endocopy
showed normal upper third esophagus, normal middle
third, stenosis in the lower third, tumor mass in cardia,
corpus and fundus of gaster were hyperplasic, fragile,
hyperemia in pylorus. The conclusion of endoscopic
result was gastric tumor mass, gastroesophageal
junction tumor. The problems of this patient were
dysphagia due to distal oesophagus tumor and
gastrooesophageal junction; esophageal candidosis;
hepatic cirrhosis; ascites suspected due to metastases.
The patient was discharge from the hospital after
30 days of treatment. His family was disapproved when
the Digestive Surgery Department would implant stent
on his esophagus.
DISCUSSION
The problem in this patient is difficulty in
swallowing that might be caused by several things such
as achalasia, tumor, and inflammation (including
bacterial, fungal). Dysphalgia results from propulsive
or structural abnormalities of either the oropharynx or
the esophagus. The structural abnormalities may
result from neoplasm, surgery, trauma, etc.8
The possible cause in this patient was tumor or
inflammation caused by Candida. Dysphagia is the most
frequently presented feature of esophageal carcinoma,
the patient may recount a short of progressive
dysphagia, thus, gradually affecting the swallowing of
fluids.6
The patient also had esophageal candidiasis which
was established due to the complaint of dysphagia and
the result from endoscopy at the distal of esophagus
there were redness and edema with focal white patches
areas, and also the result from brushing esophagus,
there were many colonization of Candida.1,2,4
Common location of esophageal candidiasis is in
the distal 2/3 of the esophagus.2 The finding of
Candida within an esophageal lesion by smear or
culture or in esophageal brushing does not allow
distinction between Candida as a commensal or
invasive pathogen. Positive esophageal brushing is
highly sensitive but very non specific in the diagnosis.2
The predisposing factors that lead esophageal
Candidiasis are diabetes mellitus, HIV, malignancy.
The predisposing factor in this patient was
immunocompromissed caused by malignancy.
Malignancy could decrease the T-lymphocytes and
T-helper cell. The development of mucosal
candidiasis is influenced by lymphocytes and
neutrophile or cellular immunity.
In this case Candidiasis was recognized before
diagnosis of malignancy established. Esophageal
Candidiasis is rarely found among imunocompetent
patient without predisposing factors. Thus, we have to
be alert of underlying disease that can lead to
imunocompromissed status. HIV infection and other
predisposing factors were not found in this patient, but
based on several examinations; it suggested that
malignancy was the underlying disease of this patient.
Absolute neutrophil count from this patient was
greater than 2,500/mm while the normal range for
 neutrophils is between 2,500 and 6,000 per cubic
millimeter of blood. An ANC below 1,000/mm is called
neutropenia, a condition that increase the risk of
infection. The level of neutropenia, less than
500 severe risk for infection, 500 – 1,000/mm
moderate risk 1,000- 1,500 minimal risk, 1,500 – 2,000
no significant risk.13 So based on that level there were
no risk for infection to this patient, but as a fact
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candida was infected him, the literature said on this
condition some level of risk of infection may still exist.
The malignancy itself may be associated with
an immune defect due to quality of neutrophil.10
Infections that commonly affect people with
cancer tend to have one feature in common – they are
often caused by germs that are normally present in
the environment and people bodies. These germs
usually do not cause infections in people with normal
protective barriers and strong immune system.9,11
Based on the terms of underlying malignancy and
the level of immunosuppression we knew that
Candida most susceptible in cancer patient with
the abnormality of qualitative defect of phagocytic
function or neutropenia and defective cell-mediated
immunity.9,10,11
Nutritional intake for this patient was liquid diet by
NGT. There are several reasons why people with
cancer often are malnourished. The cancer itself may
make eating or digestion difficult. This is common in
people with cancer in mouth, throat, or gastrointestinal
(digestive) system.9,11
Mucosal malignancy candidacies also contribute to
this condition, although esophageal candidiasis rarely
fatal but it can decrease food and fluid intake and
worsen general condition. Thus, the adequate
treatment is needed to improve symptoms of the
disease not only directly to treat the esophageal
candidiasis itself but also to improve the intake of the
patient.
Based on the diagnosis, the patient was given the
antifungal therapy Fluconazole. From the literature we
found that treatment to oropharyngeal and esophageal
candidiasis was fluconazole.Fluconazole has
markedly improved safety profiles and become the
standard of care, especially for patients with moderate
to severe oropharyngeal candidiasis (Hay 1990;
Darouiche 1998; Vasquez 2000). The goal of
antimycotic therapy in OPC is rapid relief symptoms,
prevention of complication and prevention of early
relapse following cessation of therapy.1,2,12
There were several options of antifungal drugs are
amfoterisin A, azol, and amfoterisin B. Mycostatin is
used only for imunocompetent patient. Amfoterisin B
has severe side effect and only for critically ill or
candidemia. Azol is treatment of choice for
Oropharyngeal Candidiasis.
Esophageal cancer is classified according to the
2002 American Joint Committee on Cancer tumor node
metastasis (TNM), more than 50% of patients have
unrespectable or metastasis disease at the time
presentation.6
From the recent problem of the patient, we
conclude that it was esophageal carcinoma stage IV.
Esophageal carcinoma that is treated with palliative
chemotheraphy has median survival of less than one
year. Surgery offers the most immediate and best
long-term palliation for dysphagia in patients with
localized esophageal cancer. Patient with dysphagia
may have prompt palliation of symptoms after balloon
dilatation, placement of coated, expandable metal stent,
laser ablation, or photodynamic therapy. The stenting
offers similar degrees of relief from dysphagia and at
lower cost, but that the stent may cause severe acid
reflux if extended beyond the gastroesophageal junction.6
This is a demonstrative case about gastrointestinal
malignancy with esophageal candidiasis as early
clinical presentation.
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